Insider Trading June 24, 2026 12:43 PM

J M Smucker CEO Mark T Smucker Sells $1.49M in Company Stock

Executive transaction follows strong Q4 earnings and multiple analyst upgrades, though valuation metrics suggest caution.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
SJM

J M Smucker Co CEO and Chair of the Board Mark T Smucker executed a stock sale on June 17, 2026, divesting 13,000 common shares for $1,496,430. The transaction occurs against a backdrop of robust fourth-quarter financial results and renewed analyst optimism, highlighting the intersection of executive liquidity events and fundamental business performance in the consumer staples sector.

J M Smucker CEO Mark T Smucker Sells $1.49M in Company Stock
SJM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive liquidity events like Mr. Smucker's sale impact investor sentiment and supply dynamics in the consumer staples market.
  • Strong Q4 earnings and multiple analyst upgrades reflect positive fundamental performance in the packaged food sector.
  • Valuation metrics suggest caution, as shares trade slightly above Fair Value estimates despite recent gains.

Mark T Smucker, serving as both Chief Executive Officer and Chair of the Board at J M Smucker Co (NASDAQ:SJM), executed a sale of 13,000 common shares on June 17, 2026. The transaction, which netted $1,496,430, involved shares priced between $115.08 and $115.17 each. While the stock currently trades at $111.58 and has appreciated 15% year-to-date, InvestingPro analysis indicates the shares are slightly overvalued relative to their Fair Value estimate.

Post-transaction, Mr. Smucker directly holds 82,009 common shares of J M Smucker Co. His indirect holdings include 7,576 shares via a 401(k) plan, 60,000 shares through a GRAT established in 2025, and 61,204 shares held by a Trust. Additional indirect holdings include 3,469 shares attributed to his wife, 12,770.67 shares held by Trusts FBO Son, and 12,770.67 shares held by Trusts FBO Daughter; however, Mr. Smucker disclaims beneficial ownership of these specific shares. The company maintains a 3.98% dividend yield and has sustained dividend payments for 56 consecutive years.

Recent financial disclosures show J.M. Smucker reporting fourth-quarter earnings per share of $2.77, a 20% increase from the prior year that surpassed some analyst estimates. UBS highlighted the company's strong top-line growth and operating margin, prompting an earnings beat and a price target increase to $130 with a Buy rating. Bernstein also raised its price target to $137, citing organic sales growth of 6%, driven by a 10% price increase offset by a 4% volume decline, outperforming peers in the packaged food sector. TD Cowen adjusted its price target to $115, maintaining a Hold rating while increasing earnings per share estimates for fiscal years 2027 and 2028. Stifel similarly raised its price target to $115, noting strong profit margin performance. Despite slightly weaker gross margins, UBS reiterated its Buy rating, emphasizing the company's ability to offset these with lower selling, general, and administrative expenses.

Risks

  • Slightly weaker gross margins may pressure profitability if selling, general, and administrative expense reductions are insufficient.
  • Overvaluation relative to Fair Value estimates could lead to downside risk if market conditions shift.
  • Volume declines in the packaged food sector may indicate broader consumer spending pressures affecting the staples industry.

More from Insider Trading

Executive Capital Commitment at Bed Bath & Beyond Aug 6, 2026 EXLService President Vikas Bhalla Executes $384,890 Share Sale Under Pre-Existing Trading Plan Aug 6, 2026 Arcutis Biotherapeutics Executive Divests Shares Amid Strong Financial Backdrop Aug 6, 2026 Executive Capital Deployment and Leadership Restructuring at Hanover Bancorp Aug 3, 2026 Adaptive Biotechnologies Executive Liquidates Shares as Volume Metrics Diverge From Profitability Aug 3, 2026